The MTA at 8

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 48, Issue 11, 2009, Pages 1122-

  Pliszka, Steven R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; DISEASE COURSE; LETTER; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FOLLOW-UP STUDIES; HUMANS; MULTICENTER STUDIES AS TOPIC; PROPYLAMINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 71149087935     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e3181ba3dd9     Document Type: Letter

References (4)

1. Molina B.S., Hinshaw S.P., Swanson J.M., et al. MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48 (2009) 484-500
2. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46 (2007) 894-921
3. Scheffler R.M., Brown T.T., Fulton B.D., et al. Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 123 (2009) 1273-1279
4. Tamesis G.P., and Covar R.A. Long-term effects of asthma medications in children. Curr Opin Allergy Clin Immunol 8 (2008) 163-167